Jun Yoon - Mar 15, 2025 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Jun Yoon
Stock symbol
GPCR
Transactions as of
Mar 15, 2025
Transactions value $
$0
Form type
4
Date filed
3/18/2025, 08:45 PM
Previous filing
Mar 20, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GPCR Ordinary Shares Award $0 +170K +15.15% $0.00 1.29M Mar 15, 2025 Direct F1, F2
holding GPCR Ordinary Shares 1.55M Mar 15, 2025 See footnote F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GPCR Employee Stock Option (right to buy) Award $0 +413K $0.00 413K Mar 15, 2025 Ordinary Shares 413K $7.02 Direct F1, F4, F5
transaction GPCR American Depositary Shares Award $0 +694 +115.67% $0.00 1.29K May 20, 2024 Ordinary Shares 2.08K Direct F1, F6, F7
transaction GPCR American Depositary Shares Award $0 +821 +63.45% $0.00 2.12K Nov 20, 2024 Ordinary Shares 2.46K Direct F1, F6, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2 Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.
F3 By Jun Sik Yoon and Hayung Yang Yoon, Trustees of The Yoon Family Trust, dated December 11, 2019.
F4 The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
F5 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.
F6 Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.
F7 Voluntary reporting of the acquisition of 694 ADSs by the Reporting Person on May 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan.
F8 Voluntary reporting of the acquisition of 821 ADSs by the Reporting Person on Novembery 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan.